IL204709D0 - Methods for promoting wound healing and muscle regeneration with the cell signaling protein nell1 - Google Patents

Methods for promoting wound healing and muscle regeneration with the cell signaling protein nell1

Info

Publication number
IL204709D0
IL204709D0 IL204709A IL20470910A IL204709D0 IL 204709 D0 IL204709 D0 IL 204709D0 IL 204709 A IL204709 A IL 204709A IL 20470910 A IL20470910 A IL 20470910A IL 204709 D0 IL204709 D0 IL 204709D0
Authority
IL
Israel
Prior art keywords
methods
wound healing
cell signaling
promoting wound
signaling protein
Prior art date
Application number
IL204709A
Other versions
IL204709A (en
Original Assignee
Ut Battelle Llc
Cymbeline T Culiat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US97602307P priority Critical
Priority to PCT/US2008/077845 priority patent/WO2009042859A1/en
Application filed by Ut Battelle Llc, Cymbeline T Culiat filed Critical Ut Battelle Llc
Publication of IL204709D0 publication Critical patent/IL204709D0/en
Publication of IL204709A publication Critical patent/IL204709A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/486Elastase (3.4.21.36 or 3.4.21.37)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00Medicinal preparations containing peptides
IL204709A 2007-09-28 2010-03-24 Compositions comprising nell1 or a nucleic acid coding for a nell1 protein for use in promoting skeletal muscle and skin wound healing and for treating skeletal muscle atrophy IL204709A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US97602307P true 2007-09-28 2007-09-28
PCT/US2008/077845 WO2009042859A1 (en) 2007-09-28 2008-09-26 Methods for promoting wound healing and muscle regeneration with the cell signaling protein nell 1

Publications (2)

Publication Number Publication Date
IL204709D0 true IL204709D0 (en) 2010-11-30
IL204709A IL204709A (en) 2015-09-24

Family

ID=40511872

Family Applications (1)

Application Number Title Priority Date Filing Date
IL204709A IL204709A (en) 2007-09-28 2010-03-24 Compositions comprising nell1 or a nucleic acid coding for a nell1 protein for use in promoting skeletal muscle and skin wound healing and for treating skeletal muscle atrophy

Country Status (7)

Country Link
US (3) US7910542B2 (en)
EP (1) EP2194782B1 (en)
JP (2) JP2010540557A (en)
AU (1) AU2008304280B2 (en)
CA (1) CA2699614C (en)
IL (1) IL204709A (en)
WO (1) WO2009042859A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5593226B2 (en) 2007-09-28 2014-09-17 ユーティー−バッテル・エルエルシー Treatment of cardiovascular disorders using cell differentiation signaling protein NELL1
JP5641477B2 (en) * 2008-08-04 2014-12-17 学校法人昭和大学 Tissue / organ ectopic regeneration control technology by NELL-1
WO2011091244A1 (en) * 2010-01-21 2011-07-28 NellOne Therapeutics, Inc. Methods to treat or prevent a skin condition using a nell1 peptide
JP2012012344A (en) * 2010-07-01 2012-01-19 Japan Health Science Foundation Wound healing agent
US10752663B2 (en) 2016-08-29 2020-08-25 NellOne Therapeutics, Inc. Methods and compositions for regenerating tissues
WO2021178878A1 (en) * 2020-03-06 2021-09-10 NellOne Therapeutics, Inc. Methods and compositions for treating muscle atrophy
WO2021206833A2 (en) * 2020-04-10 2021-10-14 NellOne Therapeutics, Inc. Methods and compositions for treating tissue damage resulting from viral infections

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5043900A (en) * 1999-05-24 2000-12-12 Mayo Foundation For Medical Education And Research Adenovirus vectors encoding brain natriuretic peptide
US7052856B2 (en) * 1999-10-05 2006-05-30 The Regents Of The University Of California NELL-1 enhanced bone mineralization
US7687462B2 (en) * 1999-10-05 2010-03-30 The Regents Of The University Of California Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition
US7884066B2 (en) 1999-10-05 2011-02-08 The Regents Of The University Of California NELL-1 enhanced bone mineralization
CN1538850A (en) 2001-06-08 2004-10-20 史密夫及内修公开有限公司 BMP Binding proteins for use in bone or cartilage regenearation
CN1867673A (en) * 2002-09-13 2006-11-22 加利福尼亚大学校务委员会 NELL-1 enhanced bone mineralization
CA2515208A1 (en) * 2003-02-07 2004-08-26 The Regents Of The University Of California Nell peptide expression systems and bone formation activity of nell peptide
US7691607B2 (en) 2004-02-09 2010-04-06 The Regents Of The University Of California Expression system of NELL peptide
US20060053503A1 (en) * 2004-07-30 2006-03-09 Ut-Battelle, Llc Cranial and vertebral defects associated with loss-of-function of Nell
WO2006089023A2 (en) * 2005-02-16 2006-08-24 The Regents Of The University Of California Pharmaceutical compositions for treating or preventing bone conditions
JP5593226B2 (en) 2007-09-28 2014-09-17 ユーティー−バッテル・エルエルシー Treatment of cardiovascular disorders using cell differentiation signaling protein NELL1
WO2011091244A1 (en) 2010-01-21 2011-07-28 NellOne Therapeutics, Inc. Methods to treat or prevent a skin condition using a nell1 peptide

Also Published As

Publication number Publication date
US8877176B2 (en) 2014-11-04
JP5856117B2 (en) 2016-02-09
IL204709A (en) 2015-09-24
CA2699614C (en) 2020-03-24
US7910542B2 (en) 2011-03-22
US20110250186A1 (en) 2011-10-13
JP2014001238A (en) 2014-01-09
EP2194782A4 (en) 2012-10-17
CA2699614A1 (en) 2009-04-02
AU2008304280B2 (en) 2013-10-31
AU2008304280A1 (en) 2009-04-02
US9920104B2 (en) 2018-03-20
JP2010540557A (en) 2010-12-24
US20090142312A1 (en) 2009-06-04
US20150037294A1 (en) 2015-02-05
EP2194782B1 (en) 2015-11-04
EP2194782A1 (en) 2010-06-16
WO2009042859A1 (en) 2009-04-02

Similar Documents

Publication Publication Date Title
IL204709D0 (en) Methods for promoting wound healing and muscle regeneration with the cell signaling protein nell1
IL205737D0 (en) Systems and methods for water treatment
SG10201602094RA (en) Ballast water treatment system
HK1199059A1 (en) Selective cell therapy for the treatment of renal failure
EP2366443A4 (en) Ballast water treatment system
GB0816066D0 (en) Exhaust after treatment system with pre-catalysis
EP2217371A4 (en) Catalysts and related methods
EP2240236A4 (en) Skin therapy system
EP2155084A4 (en) Bone treatment systems and methods
ZA200908799B (en) Presbyopic treatment system
EP2153120A4 (en) Lighting method and system
EP2154859A4 (en) Method for idle mode signaling reduction and the system thereof
EP2226331A4 (en) Protein purification method
EP2170311A4 (en) Compounds and methods for treating or preventing autoimmune diseases
GB0801264D0 (en) Electrically enhances wound healing system and method
ZA200809114B (en) Antisecretory protein for use in the treatment of compartment syndrome
SI2058441T1 (en) System for storing and purifying water
EP2313347A4 (en) Novel systems and methods for wastewater treatment
PL2173323T3 (en) Stimulating gel
HK1139856A1 (en) Methods for treating acute pain
EP2373658A4 (en) Stat3 inhibitors and therapeutic methods using the same
EP1919502A4 (en) Protein compositions for promoting wound healing and skin regeneration
IL214566D0 (en) Means for purifying a coagulation protein, and methods for implementing same
EP2334304A4 (en) Therapeutic bone growth and regeneration
EP2266897A4 (en) Waste conveyor and waste treating system with the same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed